Featured Content
Latest Press Releases
- Jan 11, 2021 Horizon Therapeutics plc Provides Preliminary 2020 Financial Results, Exceeding Full-Year 2020 Net Sales and Adjusted EBITDA Guidance; Provides Update on TEPEZZA® (teprotumumab-trbw) Supply and New KRYSTEXXA® (pegloticase injection) Trials
- Dec 22, 2020 Horizon Therapeutics plc to Present at the 39th Annual J.P. Morgan Healthcare Conference
- Dec 17, 2020 Horizon Therapeutics plc Announces Short-Term TEPEZZA® (teprotumumab-trbw) Supply Disruption Due to Government-Mandated (Operation Warp Speed) COVID-19 Vaccine Production
Featured Videos
Corporate Brochure
Corporate Brochure
Fact Sheets & Downloads
Logo Download
Download Horizon Logo | RGB Full Color (.jpg)
Download Horizon Logo | RGB Full Color (.png)
Download Horizon Logo | Charcoal Single Color (.jpg)
Download Horizon Logo | Charcoal Single Color (.png)
If you are looking for additional Horizon media assets, please contact corporatecommunications@horizontherapeutics.com
Media Inquiries
For U.S. media inquiries, contact:
Geoff Curtis
Senior Vice President, Corporate Affairs
media@horizontherapeutics.com
+1 (888) 506-2562
For EU media inquiries, contact:
Ray Gordon
Managing Director
ray@gordonmrm.ie
+353 (87) 2417373